{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:44:52Z","timestamp":1791546292490,"version":"4.3.4"},"reference-count":93,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.autrev.2025.103779","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:46:20Z","timestamp":1739987180000},"page":"103779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Risk relationship between six autoimmune diseases and malignancies: An umbrella review"],"prefix":"10.1016","volume":"24","author":[{"given":"Ping","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuda","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoshuang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.autrev.2025.103779_bb0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2020.03.007","article-title":"Challenges, progress, and prospects of developing therapies to treat autoimmune diseases","volume":"181","author":"Fugger","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.autrev.2025.103779_bb0010","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cac2.12283","article-title":"The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China","volume":"42","author":"Zhou","year":"2022","journal-title":"Cancer Commun (Lond)"},{"issue":"10391","key":"10.1016\/j.autrev.2025.103779_bb0015","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","article-title":"Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK","volume":"401","author":"Conrad","year":"2023","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.autrev.2025.103779_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103407","article-title":"A global assessment of incidence trends of autoimmune diseases from 1990 to 2019 and predicted changes to 2040","volume":"22","author":"Li","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103779_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102266","article-title":"The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention","volume":"80","author":"Miller","year":"2023","journal-title":"Curr Opin Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2025.103779_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102882","article-title":"Autoimmunity and cancer","volume":"20","author":"Masetti","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2025.103779_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2019.101472","article-title":"The relationships between cancer and autoimmune rheumatic diseases","volume":"34","author":"Cappelli","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103779_bb0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.autrev.2025.103779_bb0045","doi-asserted-by":"crossref","first-page":"879","DOI":"10.20892\/j.issn.2095-3941.2020.0387","article-title":"Cancer burden in China: trends, risk factors and prevention","volume":"17","author":"Sun","year":"2020","journal-title":"Cancer Biol Med"},{"issue":"1","key":"10.1016\/j.autrev.2025.103779_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26444\/aaem\/94299","article-title":"Environmental risk factors for cancer \u2013 review paper","volume":"26","author":"Lewandowska","year":"2019","journal-title":"Ann Agric Environ Med"},{"key":"10.1016\/j.autrev.2025.103779_bb0055","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.semcancer.2019.06.005","article-title":"Autoimmune diseases and hematological malignancies: exploring the underlying mechanisms from epidemiological evidence","volume":"64","author":"Hemminki","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103779_bb0060","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.autrev.2017.07.022","article-title":"Cancer and autoimmune diseases","volume":"16","author":"Giat","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103779_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.928062","article-title":"Secondary immune deficiency and primary immune deficiency crossovers: hematological malignancies and autoimmune diseases","volume":"13","author":"Ballow","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103779_bb0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.berh.2016.03.001","article-title":"Cancer and autoimmunity: harnessing longitudinal cohorts to probe the link","volume":"30","author":"Egiziano","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2025.103779_bb0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.coi.2019.07.001","article-title":"Metabolic regulation of pathogenic autoimmunity: therapeutic targeting","volume":"61","author":"Teng","year":"2019","journal-title":"Curr Opin Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2025.103779_bb0080","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","article-title":"The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies","volume":"56","author":"Rees","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.autrev.2025.103779_bb0085","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/bjc.2011.115","article-title":"Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis","volume":"104","author":"Bernatsky","year":"2011","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.autrev.2025.103779_bb0090","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s10067-017-3950-9","article-title":"No association between the risk of breast cancer and systemic lupus erythematosus: evidence from a meta-analysis","volume":"37","author":"Rezaieyazdi","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2025.103779_bb0095","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1007\/s10067-019-04660-9","article-title":"Risk of pancreatic cancer in patients with systemic lupus erythematosus: a meta-analysis","volume":"38","author":"Seo","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103779_bb0100","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.semarthrit.2021.09.009","article-title":"Risk of malignancy in patients with systemic lupus erythematosus: systematic review and meta-analysis","volume":"51","author":"Clarke","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2025.103779_bb0105","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1177\/0961203316672928","article-title":"Risk of high-grade cervical dysplasia and cervical cancer in women with systemic lupus erythematosus receiving immunosuppressive drugs","volume":"26","author":"Feldman","year":"2017","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.autrev.2025.103779_bb0110","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/art.39689","article-title":"Biologic disease-modifying Antirheumatic drugs and risk of high-grade cervical dysplasia and cervical Cancer in rheumatoid arthritis: a cohort study","volume":"68","author":"Kim","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103779_bb0115","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","article-title":"The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review","volume":"41","author":"Almutairi","year":"2021","journal-title":"Rheumatol Int"},{"issue":"10","key":"10.1016\/j.autrev.2025.103779_bb0120","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the global burden of disease study 2021","volume":"5","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.autrev.2025.103779_bb0125","doi-asserted-by":"crossref","first-page":"1036239","DOI":"10.3389\/fimmu.2022.1036239","article-title":"Exploring the molecular mechanisms and shared gene signatures between rheumatoid arthritis and diffuse large B cell lymphoma","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103779_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101964","article-title":"Identification of potential hub genes and biological mechanism in rheumatoid arthritis and non-small cell lung cancer via integrated bioinformatics analysis","volume":"45","author":"An","year":"2024","journal-title":"Transl Oncol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103779_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002672","article-title":"Dysregulated long non-coding RNA in Sj\u00f6gren\u2019s disease impacts both interferon and adaptive immune responses","volume":"8","author":"Joachims","year":"2022","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.autrev.2025.103779_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neurol.2015.10.006","article-title":"Epidemiology of multiple sclerosis","volume":"172","author":"Leray","year":"2016","journal-title":"Rev Neurol (Paris)"},{"issue":"1","key":"10.1016\/j.autrev.2025.103779_bb0145","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.0105-2896.2009.00852.x","article-title":"Genetics and genomics of ankylosing spondylitis","volume":"233","author":"Thomas","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2025.103779_bb0150","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"Bmj"},{"key":"10.1016\/j.autrev.2025.103779_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103187","article-title":"Autoimmune diseases and female-specific cancer risk: a systematic review and meta-analysis","volume":"144","author":"Fischer","year":"2024","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.autrev.2025.103779_bb0160","doi-asserted-by":"crossref","first-page":"7952","DOI":"10.1038\/s41467-024-51824-6","article-title":"An observational and genetic investigation into the association between psoriasis and risk of malignancy","volume":"15","author":"Li","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2025.103779_bb0165","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"10.1016\/j.autrev.2025.103779_bb0170","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"Bmj"},{"issue":"5","key":"10.1016\/j.autrev.2025.103779_bb0175","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10654-022-00873-6","article-title":"Sedentary behavior and cancer-an umbrella review and meta-analysis","volume":"37","author":"Hermelink","year":"2022","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.autrev.2025.103779_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408398.2023.2298772","article-title":"High and low dietary fiber consumption and cancer risk: a comprehensive umbrella review with meta-meta-analysis involving meta-analyses of observational epidemiological studies","author":"Arayici","year":"2023","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"168","key":"10.1016\/j.autrev.2025.103779_bb0185","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0009-2023","article-title":"Identifying risk factors for COPD and adult-onset asthma: an umbrella review","volume":"32","author":"Holtjer","year":"2023","journal-title":"Eur Respir Rev"},{"issue":"3","key":"10.1016\/j.autrev.2025.103779_bb0190","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/ebmental-2018-300014","article-title":"Ten simple rules for conducting umbrella reviews","volume":"21","author":"Fusar-Poli","year":"2018","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.autrev.2025.103779_bb0195","series-title":"Cochrane handbook for systematic reviews of interventions","first-page":"143","article-title":"Choosing effect measures and computing estimates of effect","author":"Higgins","year":"2019"},{"issue":"20","key":"10.1016\/j.autrev.2025.103779_bb0200","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.autrev.2025.103779_bb0205","article-title":"Publication bias in meta-analysis: prevention, assessment and adjustments","volume":"72","author":"Viechtbauer","year":"2007","journal-title":"Psychometrika"},{"issue":"9","key":"10.1016\/j.autrev.2025.103779_bb0210","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.leukres.2014.06.025","article-title":"Systemic lupus erythematosus is associated with increased incidence of hematologic malignancies: a meta-analysis of prospective cohort studies","volume":"38","author":"Apor","year":"2014","journal-title":"Leuk Res"},{"issue":"13","key":"10.1016\/j.autrev.2025.103779_bb0215","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1177\/09612033211048129","article-title":"Association between systemic lupus erythematosus and risk of cervical atypia: a meta-analysis","volume":"30","author":"Chen","year":"2021","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.autrev.2025.103779_bb0220","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.oooo.2023.07.007","article-title":"Risk and prevalence of oral cancer in patients with different types of lupus erythematosus: a systematic review and meta-analysis","volume":"136","author":"Rodrigues","year":"2023","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103779_bb0225","doi-asserted-by":"crossref","first-page":"721","DOI":"10.4103\/0973-1482.172115","article-title":"Systemic lupus erythematous increased lung cancer risk: evidence from a meta-analysis","volume":"12","author":"Wu","year":"2016","journal-title":"J Cancer Res Ther"},{"issue":"9","key":"10.1016\/j.autrev.2025.103779_bb0230","doi-asserted-by":"crossref","first-page":"614","DOI":"10.34172\/aim.2020.72","article-title":"An updated meta-analysis on the risk of urologic cancer in patients with systemic lupus erythematosus","volume":"23","author":"Yeo","year":"2020","journal-title":"Arch Iran Med"},{"issue":"9","key":"10.1016\/j.autrev.2025.103779_bb0235","first-page":"6270","article-title":"Thyroid cancer in systemic lupus erythematosus: a meta analysis","volume":"7","author":"Zhang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103779_bb0240","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1007\/s10238-023-01151-9","article-title":"Causal inference between rheumatoid arthritis and prostate cancer","volume":"23","author":"Ou","year":"2023","journal-title":"Clin Exp Med"},{"issue":"3","key":"10.1016\/j.autrev.2025.103779_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091461","article-title":"Risk of multiple myeloma in rheumatoid arthritis: a meta-analysis of case-control and cohort studies","volume":"9","author":"Shen","year":"2014","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.autrev.2025.103779_bb0250","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","article-title":"Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis","volume":"17","author":"Simon","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.autrev.2025.103779_bb0255","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/ar2404","article-title":"A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis","volume":"10","author":"Smitten","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2025.103779_bb0260","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/453012","article-title":"Breast cancer risk in rheumatoid arthritis: an update meta-analysis","volume":"2014","author":"Tian","year":"2014","journal-title":"Biomed Res Int"},{"issue":"3","key":"10.1016\/j.autrev.2025.103779_bb0265","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.semarthrit.2021.03.015","article-title":"Rheumatoid arthritis and risk of lung cancer: Meta-analysis and Mendelian randomization study","volume":"51","author":"Wu","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2025.103779_bb0270","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s10067-020-05396-7","article-title":"The risk of leukemia in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"40","author":"Luo","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103779_bb0275","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jaad.2020.09.050","article-title":"Association of psoriasis with colorectal cancer","volume":"85","author":"Fu","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103779_bb0280","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00403-023-02753-9","article-title":"Risk of breast cancer among patients with psoriasis: a systematic review and meta-analysis","volume":"316","author":"Tung","year":"2023","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"10.1016\/j.autrev.2025.103779_bb0285","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jamadermatol.2020.0024","article-title":"Prevalence, incidence, and risk of cancer in patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"156","author":"Vaengebjerg","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103779_bb0290","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.7150\/jca.37015","article-title":"Risk of non-melanoma skin cancer in patients with psoriasis: an updated evidence from systematic review with meta-analysis","volume":"11","author":"Wang","year":"2020","journal-title":"J Cancer"},{"issue":"1","key":"10.1016\/j.autrev.2025.103779_bb0295","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jaad.2021.07.050","article-title":"Risk of lymphohematologic malignancies in patients with chronic plaque psoriasis: a systematic review with meta-analysis","volume":"86","author":"Bellinato","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2025.103779_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.861984","article-title":"Ankylosing spondylitis and the risk of lung cancer: a meta-analysis and Mendelian randomization","volume":"13","author":"Ao","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.autrev.2025.103779_bb0305","doi-asserted-by":"crossref","first-page":"32063","DOI":"10.1038\/srep32063","article-title":"Risk of malignancy in ankylosing spondylitis: a systematic review and meta-analysis","volume":"6","author":"Deng","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2025.103779_bb0310","article-title":"Risk, incidence, and mortality of breast cancer in primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis","volume":"13","author":"Deng","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103779_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103084","article-title":"Primary Sj\u00f6gren\u2019s syndrome is associated with increased risk of malignancies besides lymphoma: a systematic review and meta-analysis","volume":"21","author":"Zhong","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.autrev.2025.103779_bb0320","first-page":"513","article-title":"Incidence of breast cancer in women with multiple sclerosis: systematic review and meta-analysis of observational cohort studies","volume":"51","author":"Catal\u00e1-L\u00f3pez","year":"2010","journal-title":"Rev Neurol"},{"key":"10.1016\/j.autrev.2025.103779_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104798","article-title":"Association between multiple sclerosis and cancer risk: an extensive review\/meta and Mendelian randomization analyses","volume":"76","author":"Liu","year":"2023","journal-title":"Mult Scler Relat Disord"},{"issue":"20","key":"10.1016\/j.autrev.2025.103779_bb0330","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: a meta-analysis","volume":"165","author":"Zintzaras","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.autrev.2025.103779_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.750533","article-title":"Six autoimmune disorders are associated with increased incidence of gastric cancer: a systematic review and Meta-analysis of half a million patients","volume":"12","author":"Z\u00e1dori","year":"2021","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2025.103779_bb0340","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/ijgc-2022-003570","article-title":"Do autoimmune diseases influence the onset and progression of ovarian cancer? A systematic review and meta-analysis","volume":"32","author":"Wouters","year":"2022","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.autrev.2025.103779_bb0345","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4143\/crt.2019.151","article-title":"Autoimmune diseases and gastric cancer risk: a systematic review and meta-analysis","volume":"51","author":"Song","year":"2019","journal-title":"Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.autrev.2025.103779_bb0350","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/jop.13396","article-title":"Association between autoimmune rheumatic diseases and head and neck cancer: systematic review and meta-analysis","volume":"52","author":"Batista","year":"2023","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.autrev.2025.103779_bb0355","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.leukres.2018.11.004","article-title":"Systemic lupus erythematosus and lymphoma: incidence, pathogenesis and biology","volume":"75","author":"Klein","year":"2018","journal-title":"Leuk Res"},{"issue":"6","key":"10.1016\/j.autrev.2025.103779_bb0360","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/BOR.0000000000000648","article-title":"Malignancies in systemic lupus erythematosus: an update","volume":"31","author":"Ladouceur","year":"2019","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103779_bb0365","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.berh.2017.09.013","article-title":"A review on SLE and malignancy","volume":"31","author":"Choi","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103779_bb0370","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/rheumatology\/keac316","article-title":"Cancer occurrence after SLE: effects of medication-related factors, disease-related factors and survival from an observational study","volume":"62","author":"Zhao","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2025.103779_bb0375","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2147\/IJGM.S448720","article-title":"Exploring the molecular mechanisms and shared gene signatures between systemic lupus erythematosus and bladder urothelial carcinoma","volume":"17","author":"Wang","year":"2024","journal-title":"Int J Gen Med"},{"issue":"5","key":"10.1016\/j.autrev.2025.103779_bb0380","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s11306-015-0772-0","article-title":"Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin","volume":"11","author":"Perl","year":"2015","journal-title":"Metabolomics"},{"issue":"12","key":"10.1016\/j.autrev.2025.103779_bb0385","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11926-016-0622-8","article-title":"Activation of the mechanistic target of rapamycin in SLE: explosion of evidence in the last five years","volume":"18","author":"Oaks","year":"2016","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"10.1016\/j.autrev.2025.103779_bb0390","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.semarthrit.2019.09.022","article-title":"Advances in systemic lupus erythematosus pathogenesis via mTOR signaling pathway","volume":"50","author":"He","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103779_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103112","article-title":"mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency","volume":"140","author":"Winans","year":"2023","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.autrev.2025.103779_bb0400","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s42255-022-00711-9","article-title":"Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis","volume":"5","author":"Oaks","year":"2023","journal-title":"Nat Metab"},{"issue":"1","key":"10.1016\/j.autrev.2025.103779_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243150","article-title":"Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis","volume":"16","author":"Johnson","year":"2021","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.autrev.2025.103779_bb0410","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/ije\/dyv364","article-title":"Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis","volume":"45","author":"Khankhanian","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"12","key":"10.1016\/j.autrev.2025.103779_bb0415","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1136\/jnnp.2009.195776","article-title":"Multiple sclerosis and risk of cancer: a meta-analysis","volume":"81","author":"Handel","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.autrev.2025.103779_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102650","article-title":"Risk of cancer in multiple sclerosis (MS): a systematic review and meta-analysis","volume":"19","author":"Ghajarzadeh","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.autrev.2025.103779_bb0425","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/qjmed\/hcq071","article-title":"Multiple sclerosis and lung cancer: an unexpected inverse association","volume":"103","author":"Handel","year":"2010","journal-title":"Qjm"},{"issue":"4","key":"10.1016\/j.autrev.2025.103779_bb0430","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000011219","article-title":"Cancer incidence and mortality rates in multiple sclerosis: a matched cohort study","volume":"96","author":"Marrie","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2025.103779_bb0435","doi-asserted-by":"crossref","first-page":"1154916","DOI":"10.3389\/fninf.2023.1154916","article-title":"Multiple sclerosis and breast cancer risk: a meta-analysis of observational and Mendelian randomization studies","volume":"17","author":"Fang","year":"2023","journal-title":"Front Neuroinform"},{"issue":"4","key":"10.1016\/j.autrev.2025.103779_bb0440","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/advances\/nmaa006","article-title":"Effects of popular diets on anthropometric and Cardiometabolic parameters: an umbrella review of meta-analyses of randomized controlled trials","volume":"11","author":"Dinu","year":"2020","journal-title":"Adv Nutr"},{"issue":"1","key":"10.1016\/j.autrev.2025.103779_bb0445","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/s12916-024-03716-1","article-title":"Effects of different types of intermittent fasting on metabolic outcomes: an umbrella review and network meta-analysis","volume":"22","author":"Chen","year":"2024","journal-title":"BMC Med"},{"issue":"3","key":"10.1016\/j.autrev.2025.103779_bb0450","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/j.gastro.2022.05.038","article-title":"Risk of Cancer in inflammatory bowel diseases: umbrella review and reanalysis of meta-analyses","volume":"163","author":"Piovani","year":"2022","journal-title":"Gastroenterology"},{"issue":"22","key":"10.1016\/j.autrev.2025.103779_bb0455","doi-asserted-by":"crossref","DOI":"10.3390\/nu16223873","article-title":"Effect of different dietary patterns on Cardiometabolic risk factors: an umbrella review of systematic reviews and Meta-analyses","volume":"16","author":"Chatzi","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.autrev.2025.103779_bb0460","doi-asserted-by":"crossref","first-page":"1479983","DOI":"10.3389\/fphar.2024.1479983","article-title":"Interventions for prevention and treatment of trastuzumab-induced cardiotoxicity: an umbrella review of systematic reviews and meta-analyses","volume":"15","author":"Wang","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.autrev.2025.103779_bb0465","article-title":"Umbrella review and meta-analysis: the efficacy of nonpharmacological interventions for sleep disturbances in children and adolescents","author":"Hornsey","year":"2024","journal-title":"J Am Acad Child Adolesc Psychiatry"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T04:03:56Z","timestamp":1741665836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997225000394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":93,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1568997225000394"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103779","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk relationship between six autoimmune diseases and malignancies: An umbrella review","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103779"}}